Chugai Pharmaceutical Co Ltd (CHGCY)
Chugai Pharmaceutical Market Cap: 52.65B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 52.65B |
May 16, 2024 | 51.99B |
May 15, 2024 | 51.47B |
May 14, 2024 | 50.41B |
May 13, 2024 | 51.80B |
May 10, 2024 | 51.91B |
May 09, 2024 | 52.36B |
May 08, 2024 | 52.16B |
May 07, 2024 | 52.65B |
May 06, 2024 | 54.84B |
May 03, 2024 | 54.69B |
May 02, 2024 | 54.17B |
May 01, 2024 | 52.22B |
April 30, 2024 | 52.13B |
April 29, 2024 | 51.50B |
April 26, 2024 | 50.61B |
April 25, 2024 | 51.30B |
April 24, 2024 | 52.75B |
April 23, 2024 | 55.25B |
April 22, 2024 | 54.76B |
April 19, 2024 | 52.29B |
April 18, 2024 | 53.57B |
April 17, 2024 | 53.80B |
April 16, 2024 | 54.59B |
April 15, 2024 | 53.61B |
Date | Value |
---|---|
April 12, 2024 | 54.50B |
April 11, 2024 | 56.29B |
April 10, 2024 | 55.75B |
April 09, 2024 | 58.28B |
April 08, 2024 | 58.31B |
April 05, 2024 | 59.20B |
April 04, 2024 | 59.73B |
April 03, 2024 | 60.71B |
April 02, 2024 | 59.96B |
April 01, 2024 | 61.80B |
March 28, 2024 | 62.95B |
March 27, 2024 | 64.35B |
March 26, 2024 | 64.50B |
March 25, 2024 | 63.57B |
March 22, 2024 | 63.54B |
March 21, 2024 | 64.17B |
March 20, 2024 | 66.54B |
March 19, 2024 | 66.40B |
March 18, 2024 | 67.59B |
March 15, 2024 | 66.31B |
March 14, 2024 | 67.33B |
March 13, 2024 | 69.10B |
March 12, 2024 | 71.83B |
March 11, 2024 | 72.30B |
March 08, 2024 | 72.20B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Takeda Pharmaceutical Co Ltd | 41.48B |
Nxera Pharma Co Ltd | 869.77M |
PeptiDream Inc | 1.555B |
Healios KK | 86.98M |
AnGes Inc | 72.99M |
Market Cap Related Metrics
PE Ratio | 23.28 |
PS Ratio | 7.328 |
Price to Book Value | 4.853 |
Price to Free Cash Flow | 23.65 |
Price | 16.00 |
Earnings Yield | 4.30% |
Operating PE Ratio | 17.23 |
Normalized PE Ratio | 23.28 |